US funding agency upbeat about HIV research despite SA vaccine failure
01 March 2020 - 16:37
A senior scientist from the biggest external funder of SA HIV research says he remains optimistic about the prospects of an effective vaccine, despite the failure of the HVTN 702 trial.
The experimental HVTN 702/Uhambo trial, funded by the US National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation, tested a modified version of the 2009 Thai RV144 vaccine, the only one to date to provide some protection against the virus. But the trial, which was conducted among 5,400 volunteers at 14 different sites in SA, was halted early because it did not work. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.